Evidence map›Paper›PMID 24610917›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2014

Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase.

Ramzi N El Accaoui, Sarah T Gould, Georges P Hajj, Yi Chu, Melissa K Davis, Diane C Kraft, Donald D Lund, Robert M Brooks, Hardik Doshi, Kathy A Zimmerman and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The role of microRNAs in calcific aortic valve disease.Frontiers in cardiovascular medicine · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. AMPK: Potential Therapeutic Target for Vascular Calcification.Frontiers in cardiovascular medicine · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Ramzi N El AccaouiDivision of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa;
Sarah T Gould
Georges P Hajj
Yi Chu
Melissa K Davis
Diane C Kraft
Donald D Lund
Robert M Brooks
Hardik Doshi
Kathy A Zimmerman
William Kutschke
Kristi S Anseth
Donald D Heistad
Robert M Weiss
University of Iowa · USUniversity of Colorado Boulder · US

Funding

Vascular Protection During HypertensionP01HL062984 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2000 to 2015
$22.2M
Bioactive Hydrogel Niches for 3D VIC CultureR01HL089260 · NHLBI · UNIVERSITY OF COLORADO · PI ANSETH, KRISTI S. · 2008 to 2011
$1.3M
Howard Hughes Medical InstituteNHLBI NIH HHS HL-062984NHLBI NIH HHS HL-089260NHLBI NIH HHS P01 HL062984
6 · The paper itself

Abstract

Risk factors for fibrocalcific aortic valve disease (FCAVD) are associated with systemic decreases in bioavailability of endothelium-derived nitric oxide (EDNO). In patients with bicuspid aortic valve (BAV), vascular expression of endothelial nitric oxide synthase (eNOS) is decreased, and eNOS(-/-) mice have increased prevalence of BAV. The goal of this study was to test the hypotheses that EDNO attenuates profibrotic actions of valve interstitial cells (VICs) in vitro and that EDNO deficiency accelerates development of FCAVD in vivo. As a result of the study, coculture of VICs with aortic valve endothelial cells (vlvECs) significantly decreased VIC activation, a critical early phase of FCAVD. Inhibition of VIC activation by vlvECs was attenuated by N(G)-nitro-l-arginine methyl ester or indomethacin. Coculture with vlvECs attenuated VIC expression of matrix metalloproteinase-9, which depended on stiffness of the culture matrix. Coculture with vlvECs preferentially inhibited collagen-3, compared with collagen-1, gene expression. BAV occurred in 30% of eNOS(-/-) mice. At age 6 mo, collagen was increased in both bicuspid and trileaflet eNOS(-/-) aortic valves, compared with wild-type valves. At 18 mo, total collagen was similar in eNOS(-/-) and wild-type mice, but collagen-3 was preferentially increased in eNOS(-/-) mice. Calcification and apoptosis were significantly increased in BAV of eNOS(-/-) mice at ages 6 and 18 mo. Remarkably, these histological changes were not accompanied by physiologically significant valve stenosis or regurgitation. In conclusion, coculture with vlvECs inhibits specific profibrotic VIC processes. In vivo, eNOS deficiency produces fibrosis in both trileaflet and BAVs but produces calcification only in BAVs.

Indexed as

AnimalsAortic ValveApoptosisBicuspid Aortic Valve DiseaseCalcinosisCells, CulturedCollagen Type ICollagen Type IIIHeart Defects, CongenitalHeart Valve DiseasesInterstitial Cells of CajalMatrix Metalloproteinase 9MiceNitric Oxide Synthase Type IIISclerosisSwineCollagen Type ICollagen Type IIIMatrix Metalloproteinase 9Nitric Oxide Synthase Type IIINos3 protein, mouseaortic valve sclerosisbicuspid aortic valveendothelial nitric oxide synthase

Identifiers

PMID24610917
PMCPMC4010666
OpenAlexW2139815734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.